Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Abstract Text:

Edward J Mills,Jean B Nachega,David R Bangsberg,Sonal Singh,Beth Rachlis,Ping Wu,Kumanan Wilson,Iain Buchan,Christopher J Gill,Curtis Cooper,

BACKGROUND: Adherence to highly active antiretroviral therapy (HAART) medication is the greatest patient-enabled predictor of treatment success and mortality for those who have access to drugs. We systematically reviewed the literature to determine patient-reported barriers and facilitators to adhering to antiretroviral therapy. METHODS AND FINDINGS: We examined both developed and developing nations. We searched the following databases: AMED (inception to June 2005), Campbell Collaboration (inception to June 2005), CinAhl (inception to June 2005), Cochrane Library (inception to June 2005), Embase (inception to June 2005), ERIC (inception to June 2005), MedLine (inception to June 2005), and NHS EED (inception to June 2005). We retrieved studies conducted in both developed and developing nation settings that examined barriers and facilitators addressing adherence. Both qualitative and quantitative studies were included. We independently, in duplicate, extracted data reported in qualitative studies addressing adherence. We then examined all quantitative studies addressing barriers and facilitators noted from the qualitative studies. In order to place the findings of the qualitative studies in a generalizable context, we meta-analyzed the surveys to determine a best estimate of the overall prevalence of issues. We included 37 qualitative studies and 47 studies using a quantitative methodology (surveys). Seventy-two studies (35 qualitative) were conducted in developed nations, while the remaining 12 (two qualitative) were conducted in developing nations. Important barriers reported in both economic settings included fear of disclosure, concomitant substance abuse, forgetfulness, suspicions of treatment, regimens that are too complicated, number of pills required, decreased quality of life, work and family responsibilities, falling asleep, and access to medication. Important facilitators reported by patients in developed nation settings included having a sense of self-worth, seeing positive effects of antiretrovirals, accepting their seropositivity, understanding the need for strict adherence, making use of reminder tools, and having a simple regimen. Among 37 separate meta-analyses examining the generalizability of these findings, we found large heterogeneity. CONCLUSIONS: We found that important barriers to adherence are consistent across multiple settings and countries. Research is urgently needed to determine patient-important factors for adherence in developing world settings. Clinicians should use this information to engage in open discussion with patients to promote adherence and identify barriers and facilitators within their own populations.

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Publishing Authors By Initials

EJ Mills,JB Nachega,DR Bangsberg,S Singh,B Rachlis,P Wu,K Wilson,I Buchan,CJ Gill,C Cooper,

For similar behavior and behavior mechanisms: behavior: health behavior: patient compliance research abstracts see: behavior and behavior mechanisms: behavior: health behavior: patient compliance research

PUBMED ID PMID:

MEDLINE DATE:

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Journal Published:

PUBLICATION TYPE: Review

Journal: PLoS medicine

VOLUME: 3

Page Numbers: e438

Journal Abbreviation: PLoS Med.

ISSN: 1549-1676

DAY: 3

MONTH: Nov

YEAR: 2006

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Information

Number of References: 108

LANGUAGE: eng

NlmUniqueID: 101231360

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Keywords Mesh Terms:

KEYWORDS: Patient Compliance

MESH TERMS:

Chemical & Substance for Abstract: Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

AFFILIATION: Centre for International Health and Human Rights Studies, Toronto, Ontario, Canada. millsej@univmail.cis.mcmaster.ca

Country: United States

AGENCY: United States NIMH

GRANT: MH54907

ACRONYM: MH

MEDLINETA: PLoS Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators Related Publications

• A bichromatic fluorescent reporter for cell-based screens of alternative splicing.
• A classical likelihood based approach for admixture mapping using EM algorithm.
• Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.
• Binding of myotrophin/V-1 to actin-capping protein: implications for how capping protein binds to the filament barbed end.
• Body fat and circulating leukocytes in children.
• CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
• Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status.
• Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma?
• Effect of rhIL-6 infusion on GH-->IGF-I axis mediators in humans.
• Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
• Evaluation of daily home spirometry for school children with asthma: new insights.
• Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques.
• Issues in maintenance and repairs of wheelchairs: A pilot study.
• LINE-1 Endonuclease-Dependent Retrotranspositional Events Causing Human Genetic Disease: Mutation Detection Bias and Multiple Mechanisms of Target Gene Disruption.
• Lymphoid reconstruction and vaccines.
• Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2.
• Measurement of some novel concepts in psychiatry.
• Patient-specific models for predicting the outcomes of patients with community acquired pneumonia.
• Primitive hematopoietic cell populations reside in the spleen: Studies in the pig, baboon, and human.
• Progress in xenotransplantation following the introduction of gene-knockout technology.
• Quantification of small molecule-receptor affinities and kinetics by acoustic profiling.
• Regional Strength in CAM.
• Regulation of DNA synthesis in bacteria: Analysis of the Bates/Kleckner licensing/initiation-mass model for cell cycle control.
• Shoulder joint kinetics and pathology in manual wheelchair users.
• Stem Cells and CAM.
• The effect of genetic variation in angiotensinogen on serum levels and blood pressure: a comparison of Nigerians and US blacks.
• The impact of FSANZ labelling changes on knowledge of nutrition and allergens by consumer's, health professional's and allergen sufferers.
• The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production.
• Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A.1 macrophage cell line.
• eCAM: On To Year 4.